Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2020 / Cilt: 34 - Sayı: 1

Evaluation of Noninvasive Biochemical Markers For Predicting Liver Histology in Chronic Hepatitis B Patients

Kronik Hepatit B Hastalarında Karaciğer Histolojisini Öngörmede Noninvaziv Biyokimyasal Belirteçlerin Değerlendirilmesi

Pages
1–6
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is determined that, high serum alanine aminotransferase, aspartate aminotransferase, prothrombin time, gamma glutamyl transpeptidase, alpha-fetoprotein, HBV-DNA levels (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In recent years, noninvasive tests have been developed by chronic hepatitis B patients, which may be an alternative to liver biopsy for predict histology.
📊
Key Findings & Data:Materials and Methods: The patients who were diagnosed as chronic hepatitis B,are older than 18, HbeAg negative, with HBV DNA level >2000 IU/mL, underwent liver biopsy and under follow up at infectious diseases department of our hospital from August 01, 2012 to August 31, 2019 were included in this study.
💡
Conclusion & Impact:It is determined that, high serum alanine aminotransferase, aspartate aminotransferase, prothrombin time, gamma glutamyl transpeptidase, alpha-fetoprotein, HBV-DNA levels (P
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In recent years, noninvasive tests have been developed by chronic hepatitis B patients, which may be an alternative to liver biopsy for predict histology. This study aimed to evaluate the relationship between the stage of fibrosis in liver biopsy and basic serum biochemical parameters of HbeAg negative chronic hepatitis B patients. Materials and Methods: The patients who were diagnosed as chronic hepatitis B,are older than 18, HbeAg negative, with HBV DNA level >2000 IU/mL, underwent liver biopsy and under follow up at infectious diseases department of our hospital from August 01, 2012 to August 31, 2019 were included in this study. Demographic characteristics and laboratory results were collected from patient files retrospectively. Repetitive patients were excluded. The patients were divided into three groups as mild fibrosis (F≤2), moderate fibrosis (F3-4) and cirrhosis (F5-6) according to Ishak fibrosis score. The patients with fibrosis score 5-6 were excluded due to inadequate number of the patients. Results: In this study, 242 patients were enrolled. Number of male were 154 (63.6%) and female were 88 (36.4%) with a mean age of 40.84±11.06. Fibrosis score was higher in male and older age. It is determined that, high serum alanine aminotransferase, aspartate aminotransferase, prothrombin time, gamma glutamyl transpeptidase, alpha-fetoprotein, HBV-DNA levels (P

Özet

Amaç: Kronik hepatit B hastalarında, son yıllarda karaciğer histolojisini öngörmek için karaciğerbiyopsisine alternatif olabileceği düşünülen noninvazif testler ortaya çıkmıştır. Bu çalışma ileHBeAg negatif kronik hepatit B hastalarının karaciğer biyopsisindeki fibrozisin derecesi ile temelserum biyokimyasal parametreleri arasındaki ilişkinin araştırılması amaçlandı.Gereç ve Yöntemler: Çalışmaya, kronik hepatit B tanısı ile hastanemiz Enfeksiyon HastalıklarıKliniği’nde 01 Ağustos 2012 ile 31 Ağustos 2019 tarihleri arasında takip edilen 18 yaş üzeri, HBeAgnegatif ve HBV-DNA düzeyi >2000 IU/mL olup karaciğer biyopsisi yapılmış hastalar dahil edildi.Hasta dosyaları taranarak bireylerin demografik özellikleri, laboratuvar sonuçları kaydedildi vetekrarlayan hastalar değerlendirmeye alınmadı. Hastalar Ishak fibrozis skoruna göre gruplandı vehafif fibrozis (F≤2), orta derecede fibrozis (F3-4), siroz (F5-6) olanlar şeklinde üç gruba ayrıldı.Fibrozis skoru 5-6 olanlar sayı azlığı nedeniyle çalışma dışı bırakıldı.Bulgular: Çalışmaya 242 hasta alındı. Hastaların 154’ü (%63.6) erkek ve 88'i (%36.4) kadın olup,yaş ortalaması 40.84±11.06 idi. Fibrozis skoru erkek cinsiyet ve ileri yaşta daha yüksekti. Skor veevre ilerledikçe hastalarda daha yüksek serum alanin aminotransferaz, aspartat aminotransferaz,protrombin zamanı, gama glutamil transpeptidaz, alfa-fetoprotein ve HBV-DNA seviyeleri (P

🔖

Cite This Article

ERTÜRK, Ü. Ş., KARLIDAĞ, G. E. (2022). Evaluation of Noninvasive Biochemical Markers For Predicting Liver Histology in Chronic Hepatitis B Patients. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 34 - Sayı: 1, 1–6. https://ajindex.com/articles/514453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. European Association for the Study of the Liver. Electronic address: [email protected]; European. J Hepatol 2017; 67: 370-398
  2. EASL Jury. EASL International consensus conference on hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003; 38: 533-540
  3. Van Thiel DH, Gavaler JS, Wright H, Tzakis A. Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation 1993; 55: 1087-1090
  4. Li Y, Huang YS, Wang ZZ, et al. Systematic review with meta-analysis: The diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B Aliment Pharmacol Ther 2016; 43: 458-469
  5. European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015; 63: 237-64
  6. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696- 699
  7. Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol 2016; 16: 509-523
  8. Schütz E, Fischer A, Beck J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med 2017; 14: e1002286
  9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520
  10. Kew MC. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 2000; 355: 591-592
  11. Xia WY, Gao L, Dai EH, et al. Liquid biopsy for noninvasive assessment of liver injury in hepatitis B patients. World J Gastroenterol 2019; 25: 3985-3995
  12. Aktug Demir N, Kolgelier S, Ozcimen S, et al. Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters. Hepat Mon 2014; 14: e16975
  13. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686
  14. Croagh CM, Bell SJ, Slavin J, et al. Increasing hepatitis B viral load is